{"count": 2, "results": [{"_id": "32125970", "pmid": 32125970, "title": "A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex.", "journal": "Respir Med", "authors": ["Krymskaya VP", "Courtwright AM", "Fleck V", "Dorgan D", "Kotloff R", "McCormack FX", "Kreider M"], "date": "2020-03-01T00:00:00Z", "doi": "10.1016/j.rmed.2020.105898", "meta_date_publication": "2020 Mar", "meta_volume": "163", "meta_issue": "", "meta_pages": "105898", "score": 50265.73, "text_hl": "A phase II clinical trial of the Safety Of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (SOS) in @SPECIES_9606 @@@patients@@@ with @DISEASE_Lymphangioleiomyomatosis @DISEASE_MESH:D018192 @@@pulmonary lymphangioleiomyomatosis@@@ and with @<m>DISEASE_Tuberous_Sclerosis</m> @DISEASE_MESH:D014402 @@@tuberous sclerosis complex@@@.", "citations": {"NLM": "Krymskaya VP, Courtwright AM, Fleck V, Dorgan D, Kotloff R, McCormack FX, Kreider M. A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex. Respir Med. 2020 Mar;163():105898. PMID: 32125970", "BibTeX": "@article{32125970, title={A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex.}, author={Krymskaya VP and Courtwright AM and Fleck V and Dorgan D and Kotloff R and McCormack FX and Kreider M}, journal={Respir Med}, volume={163}, pages={105898}}"}}, {"_id": "23947572", "pmid": 23947572, "title": "Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.", "journal": "Am J Respir Cell Mol Biol", "authors": ["Atochina-Vasserman EN", "Goncharov DA", "Volgina AV", "Milavec M", "James ML", "Krymskaya VP"], "date": "2013-11-01T00:00:00Z", "doi": "10.1165/rcmb.2013-0203RC", "meta_date_publication": "2013 Nov", "meta_volume": "49", "meta_issue": "5", "meta_pages": "704-9", "score": 50062.78, "text_hl": "These findings have translational significance for combinatorial therapeutic strategies of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to inhibit @GENE_TSC2 @GENE_7249 @@@TSC2@@@-null cell survival in @<m>DISEASE_Tuberous_Sclerosis</m> @DISEASE_MESH:D014402 @@@TS@@@ and @DISEASE_Lymphangioleiomyomatosis @DISEASE_MESH:D018192 @@@LAM@@@.", "citations": {"NLM": "Atochina-Vasserman EN, Goncharov DA, Volgina AV, Milavec M, James ML, Krymskaya VP. Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling. Am J Respir Cell Mol Biol. 2013 Nov;49(5):704-9. PMID: 23947572", "BibTeX": "@article{23947572, title={Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.}, author={Atochina-Vasserman EN and Goncharov DA and Volgina AV and Milavec M and James ML and Krymskaya VP}, journal={Am J Respir Cell Mol Biol}, volume={49}, number={5}, pages={704-9}}"}}]}